Showing results (31-40 of 51) with videos related to
Sort By:
Pageof 6
Antiviral Research|May 12, 2009
Replicons from genotype 1b HCV-positive sera exhibit diverse sensitivities to anti-HCV reagentsGo Nishimura, Masanori Ikeda, Kyoko Mori, et al.Genes|October 23, 2021
Angiotensin-Converting Enzyme (ACE) 1 Gene Polymorphism and Phenotypic Expression of COVID-19 SymptomsNaoki Yamamoto, Nao Nishida, Rain Yamamoto, et al.Plos One|January 26, 2011
The ESCRT system is required for hepatitis C virus productionYasuo Ariumi, Misao Kuroki, Masatoshi Maki, et al.Journal of Virology|August 1, 2008
The DNA damage sensors ataxia-telangiectasia mutated kinase and checkpoint kinase 2 are required for hepatitis C virus RNA replicationYasuo Ariumi, Misao Kuroki, Hiromichi Dansako, et al.Journal of Leukocyte Biology|March 28, 2023
iPS cell-derived model to study the interaction between tissue macrophage and HIV-1Youssef M Eltalkhawy, Naofumi Takahashi, Yasuo Ariumi, et al.Journal of Virology|September 15, 2007
DDX3 DEAD-box RNA helicase is required for hepatitis C virus RNA replicationYasuo Ariumi, Misao Kuroki, Ken-ichi Abe, et al.Virus Research|July 8, 2008
A new living cell-based assay system for monitoring genome-length hepatitis C virus RNA replicationHiromichi Dansako, Masanori Ikeda, Ken-ichi Abe, et al.Journal of Virology|May 6, 2011
Hepatitis C virus hijacks P-body and stress granule components around lipid dropletsYasuo Ariumi, Misao Kuroki, Yukihiro Kushima, et al.Gene|July 7, 2020
SARS-CoV-2 infections and COVID-19 mortalities strongly correlate with ACE1 I/D genotypeNaoki Yamamoto, Yasuo Ariumi, Nao Nishida, et al.FEBS Open Bio|May 8, 2013
Raloxifene inhibits hepatitis C virus infection and replicationMidori Takeda, Masanori Ikeda, Kyoko Mori, et al.Pageof 6